Drugs / PRT-2761
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03320434 | Oct 2017 → Feb 2018 | conjunctivitis | ORA, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRT-2761 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03320434 ↗ |
| Route | Topical | “topical ophthalmic solution” NCT03320434 ↗ |